Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting in Patients Without Acute Coronary Syndrome

NCT05380063 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.

NCT NCT05380063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05380063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting in Patients Without Acute Coronary Syndrome
Lead sponsor
China National Center for Cardiovascular Diseases
Phase
Phase 4
Overall status
Completed
Start date
February 14, 2023
Completion date
July 10, 2025
Enrollment
2,300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angina pectoris, bleeding, coronary artery bypass grafting, coronary artery disease, dual antiplatelet therapy, myocardial infarction, myocardial ischemia